← FDA Drug Approvals (Drugs@FDA)
TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER
NDA · New Drug Application · Sponsor: BAXTER HLTHCARE · Approved 1995-10-23
Drug application
- FDA Application #
NDA020147- Application type
- New Drug Application
- Brand name
- TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER
- Generic name
- Amino Acids
- Active ingredients
- AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- BAXTER HLTHCARE
- First approval
- 1995-10-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown